Light Chain Bioscience, a clinical-stage biotechnology company advancing the next generation of bispecific antibodies to treat cancer, today presented positive results from a Phase 1/1b study of ...

Investor event to provide update on pivotal Phase 3 study of IMNN-001 to be held in New York City on November 10, 2025Program will feature ...

At this stage of life, it's vital to lift weights, avoid getting too thin, reduce alcohol and keep up to date with jabs ...